[1] 伏瑞祥,顾峰,王煜斐,等.奥扎格雷联合依达拉奉治疗老年急性进展性脑梗死的临床观察[J].临床合理用药杂志,2017,10(4):10.
[2] 王新占.奥扎格雷联合依达拉奉治疗进展性脑梗死45例临床分析[J].中国实用神经疾病杂志,2012,15(12):38.
[3] ZHEN X,ZHENG Y,HONG X,et al.Physiological ischemic training promotes brain collateral formation and improves functions in patients with acute cerebral infarction[J].Front Neurol,2016,22(7):235.
[4] 彭明强,夏成才,胡守玮,等.奥扎格雷联合依达拉奉治疗急性脑梗死疗效观察[J].中国实用神经疾病杂志,2014,17(4):87.
[5] 李蒙,张维雄.依达拉奉联合奥扎格雷注射液治疗急性脑梗死疗效观察[J].现代诊断与治疗,2016,27(3):461.
[6] 李辉.奥扎格雷联合依达拉奉注射液治疗大面积脑梗死的临床疗效分析[J].齐齐哈尔医学院学报,2016,37(15):1942.
[7] GON Y,SAKAGUCHI M,OYAMA N,et al.Diagnostic utility of contrast-enhanced 3D T1-weighted imaging in acute cerebral infarction associated with graves disease[J].J Stroke Cerebrovasc Dis,2017,26(2):38.
[8] 唐煜明,顾海军.依达拉奉联合奥扎格雷钠治疗急性脑梗死47例临床观察[J].吉林医学,2012,33(8):1620.
[9] 朱方方,张友好,冯敏,等.同型半胱氨酸、超敏C反应蛋白、低密度脂蛋白、三酰甘油、总胆固醇与急性脑梗死的关系研究[J].蚌埠医学院学报,2016,41(5):623.
[10] 骆嵩,屈洪党,刘晓林,等.磁敏感加权成像早期评价急性脑梗死病人预后及脑血容量的相关性分析[J].蚌埠医学院学报,2016,41(4):462.
[11] KIM H,BYUN JS,HALLETT M,et al.Multifocal myoclonus as a manifestation of acute cerebral infarction recovered by carotid arterial stenting[J].J Mov Disord,2017,10(1):64.
[12] BAE HW,KIM HD,CHOI SW,et al.Acute cerebral infarction as a rare thrombotic event in myelodysplastic syndrome:a case report[J].Ann Rehabil Med,2016,40(6):1144.
[13] 罗蓉.奥扎格雷联合依达拉奉治疗急性脑梗死248例临床疗效观察[J].当代临床医刊,2016,29(4):2349.
[14] 程瑾霞.奥扎格雷和依达拉奉联合治疗进展性脑梗死的临床效果分析[J].深圳中西医结合杂志,2014,24(4):41.
[15] SHINOHARA Y,KATO A,YAMASHITA E,et al.R2* map by IDEAL IQ for acute cerebral infarction:compared with susceptibility vessel sign on T2*-weighted imaging[J].Yonago Acta Med,2016,59(3):204.